最新
每日新闻
2026年5月22日•3 分钟阅读
WHO Calls for Greater Transparency in Pharmaceutical Pricing
The World Health Organization urges member states to adopt standardized frameworks for medicine pricing disclosure to improve market access globally.
每日新闻
2026年5月21日•3 分钟阅读
Pfizer Expands API Manufacturing Capacity in Singapore
Pfizer announces a $400M investment to expand active pharmaceutical ingredient production capabilities at its Singapore facility.
每日新闻
2026年5月20日•3 分钟阅读
Global Pharma Market Expected to Hit $1.9 Trillion by 2027
New industry forecasts project the global pharmaceutical market will surpass $1.9 trillion by 2027, driven by biologics growth and expanding emerging markets.
法规动态
2026年5月18日•3 分钟阅读
FDA Releases Updated Guidance on Continuous Manufacturing for Drug Substances
The US FDA has issued new draft guidance clarifying regulatory expectations for continuous manufacturing processes in drug substance production.
市场分析
2026年5月17日•3 分钟阅读
Biosimilars Market: Growth Drivers and Competitive Dynamics in 2025
An in-depth look at how biosimilar adoption is reshaping pharmaceutical pricing, supply chains, and competitive strategies across major markets.
法规动态
2026年5月16日•3 分钟阅读
EMA Updates GMP Requirements for Advanced Therapy Medicinal Products
The European Medicines Agency has published revised GMP guidelines for ATMPs including gene therapies, cell therapies, and tissue-engineered products.
市场分析
2026年5月15日•3 分钟阅读
Contract Manufacturing in Asia Pacific: Strategic Opportunities for 2025-2027
Asia-Pacific CDMO capacity is expanding rapidly. We analyze where the highest-value opportunities lie for pharma companies seeking manufacturing partners.
法规动态
2026年5月13日•3 分钟阅读
ICH Q12 Implementation: Post-Approval Change Management Protocols
A practical overview of how pharmaceutical manufacturers are implementing ICH Q12 lifecycle management principles into their post-approval change management workflows.
研究与报告
2026年5月12日•3 分钟阅读
State of Pharmaceutical Supply Chain Resilience 2025
A comprehensive analysis of supply chain vulnerabilities, risk mitigation strategies, and technology adoption trends across global pharmaceutical supply networks.